Skip to main content

Table 3 Prevalence of infection and distribution of HCV genotypes among people who used illicit drugs

From: Hepatitis C virus infection status and associated factors among a multi-site sample of people who used illicit drugs in the Amazon region

Marker

Prevalence

95% CI

Positive/Total

%

HCV infection

 All (EIA+)

577/1666

34.6

28.3–41.1

 Active (EIA+ and PCR+)

384/1666

23.0

17.9–28.9

 Non-active (EIA+ Immuno Blot+ and PCR -)

193/1666

11.6

5.5–18.4

Genotypes

 Genotype 1

308/384

80.2

75.7–85.2

 Genotype 3

72/384

18.8

12.7–25.0

 Genotype 1 + Genotype 3

4/384

1.0

0.0–4.6